Combined Pathological Response and PEPI Score Improves Long-term Prognostic Stratification in HR-positive Breast Cancer Following Neoadjuvant Endocrine Therapy
Background/Aim: Neoadjuvant endocrine therapy (NET) is increasingly used in hormone receptor (HR)-positive breast cancer; however, optimal methods for predicting long-term outcomes remain limited. This study aimed to evaluate the prognostic value of pathological response and preoperative endocrine prognostic index (PEP...